Skip to content

MondayNightIBD | Small Bowel Adenocarcinoma | May 1, 2023 | Daniel Stein, MD ***Post-Survey & Application for CME Credit***

In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of at least 100% on this post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements. 

There is no fee to participate in this activity.
1.Where are you in your career? (Required.)
2.What is your community of practice?(Required.)
3.Which one is true regarding small bowel carcinoma in patients with Crohn’s disease?(Required.)
4.45 year old male with isolated ileal Crohn’s diagnosed 10 years ago and in remission on adalimumab for the last 5 years presents for follow-up. He heard about the increase in risk  of small bowel cancer and asks what he can do about it. What information do you share with him?(Required.)
EVALUATION FORM
5.Upon completion of this activity, I am able to:
Strongly agree
Agree
Disagree
Strongly disagree
IDENTIFY guideline-directed strategies and best practices for the care of patients with IBD
EVALUATE complex clinical situations in which patients with IBD may benefit from management strategies including novel therapeutics
EMPLOY a patient-centered approach in IBD shared-decision making
6.Please indicate the extent of your agreement with the following statements:
Strongly agree
Agree
Disagree
Strongly disagree
The faculty for this activity were effective
The educational resources provided to me at the educational activity are useful to my practice
7.Overall, was this activity fair, balanced and free from commercial bias?
8.If no, please explain:
9.Of the patients you will see in the next month, about how many will benefit from the information you learned today?
10.Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):
11.Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):
12.For purposes of certification, please complete the following information. *Please note that we will not forward or sell your contact information.*(Required.)
13.I certify that I have participated in the continuing education activity entitled, "MondayNightIBD | Small Bowel Adenocarcinoma" and claim 1.0 AMA PRA Category 1 CreditTM.(Required.)
Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4 weeks to receive your certificate. 

For information about the certification of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Privacy & Cookie Notice